Queensland Biotechnology startup, Vaxxas has formed a new partnership with Queensland Micro and Nanotechnology Centre (QMNC) at Griffith University to help boost nanotechnology commercialisation.
Vaxxas hold patents over one of the world most exciting biotechnology products, the Nanopatch™, which is a safer, more reliable and durable delivery system for vaccines than needles. QMNC is one of Queensland’s most advanced laboratories, previously focussing on new technologies in energy storage and distribution.
The agreement with Griffith sees a Vaxxas micro-manufacturing specialist employed full-time within the manufacturing laboratory at the Nathan campus, building precision-machined parts and equipment for Vaxxas.
The exchange of resources, rather than money, is not new within the industry, though at a University it usually involves research, rather than technical expertise.
The deal was brokered by the University’s commercialisation office, Griffith Enterprise and is part of a broader advanced manufacturing drive Griffith has been developing over the last five years.
Director of QMNC, Professor Nam-Trung
Skip to content
News and other stories about real people, places, and events in Mount Gravatt and nearby suburbs.